Glaucoma is the leading cause of blindness throughout the world (after cataracts); therefore,
general physicians should be familiar with the diagnosis and management of affected …

In glaucoma, lowered intraocular pressure (IOP) confers neuroprotection. Elevated IOP
characterizes glaucoma and arises from impaired aqueous humor (AH) outflow. Increased …

Glaucoma remains only partially understood, particularly at the level of intraocular pressure
(IOP) regulation. Trabecular meshwork (TM) and Schlemm's canal inner wall endothelium …

Over the last decade several novel surgical treatment options and devices for glaucoma
have been developed. All these developments aim to cause as little trauma as possible to …

Glaucoma is a progressive optic neuropathy that is the second leading cause of preventable
blindness worldwide, after cataract formation. A rise in the intraocular pressure (IOP) is …

Purpose Selective laser trabeculoplasty (SLT) is a common treatment option for managing
glaucoma and ocular hypertension. We assessed the real-world effectiveness of SLT and …

Purpose: To evaluate aqueous humor outflow (AHO) in intact eyes of live human subjects
during cataract surgery using fluorescein aqueous angiography. Methods: Aqueous …

Elevated intraocular pressure (IOP) is the predominant risk factor for glaucoma, and
reducing IOP is the only successful strategy to prevent further glaucomatous vision loss. IOP …

Purpose To evaluate the feasibility of safely performing aqueous angiography in intact eyes
of living nonhuman primates (NHPs) for evaluating aqueous humor outflow and segmental …

Purpose: To assess the ability of trabecular micro-bypass stents to improve aqueous humor
outflow (AHO) in regions initially devoid of AHO as assessed by aqueous angiography …